David Snyder
Directeur Financier/CFO chez COYA THERAPEUTICS, INC.
Fortune : 59 010 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Matthias G. Schroff | M | 56 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 6 ans |
| Timothy Walbert | M | 57 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 ans |
| Howard Berman | M | 50 | 4 ans | |
| Bali Muralidhar | M | 44 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 ans |
| Bosun Hau | M | 45 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 4 ans |
| Jeffrey L. Cleland | M | 59 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 5 ans |
| Hideki Garren | M | 60 | 3 ans | |
| Chad A. Mirkin | M | 60 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 13 ans |
| Fred Grossman | M | 62 | 1 ans | |
| Christopher Kendrick-Parker | M | 59 | 16 ans | |
| Dov Goldstein | M | 56 | 3 ans | |
| Anna M Geyso | F | 60 | 13 ans | |
| Ann Lee | M | 62 | 3 ans | |
| Arun Swaminathan | M | - | 1 ans | |
| Jeffrey Raizer | M | - |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | - |
| Jessica Starman | F | - | - | |
| Anabella Villalobos | M | 65 | 3 ans | |
| Wilbur Ross | M | 85 | 1 ans | |
| Michaelle Jean | F | 66 |
University of Ottawa
| 12 ans |
| Dieter Weinand | M | 63 | 1 ans | |
| John M. Centanni | M | - | 2 ans | |
| Jay Venkatesan | M | 52 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 10 ans |
| Helen Kim | F | 61 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 10 ans |
| David Walt | M | 71 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | 11 ans |
| Michelle Frazier | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Elias D. Papadimas | M | 48 | 8 ans | |
| Emile Nuwaysir | M | 55 | - | |
| Leonard J. Loventhal | M | 64 | 3 ans | |
| Timothy D. Daley | M | 55 | - | |
| Michael van Handel | M | 64 | 5 ans | |
| Stan Rose | M | 68 | 6 ans | |
| Kenneth C. Hunt | M | 74 | 6 ans | |
| Michael Edward Falk | M | 57 | 3 ans | |
| Sheli Rosenberg | F | 82 | 2 ans | |
| Colby Shad Thaxton | M | - | 8 ans | |
| Adrian Hepner | M | 62 | 2 ans | |
| Michelle Silva Wangham | M | 48 |
University of Ottawa
| 3 ans |
| Weston Daniel | M | - | 3 ans | |
| Christoph Jaeker | M | - | - | |
| Diego Garzón | M | - | - | |
| Suzie Cusson | F | - |
University of Ottawa
| 3 ans |
| Madison Elkhazin | F | - |
University of Ottawa
| 4 ans |
| Dhanbir Jaswal | M | 36 |
University of Ottawa
| 3 ans |
| Alex Chevrette | M | - |
University of Ottawa
| 4 ans |
| Jason Hunt | M | - |
University of Ottawa
| 5 ans |
| Chi Le | F | - |
University of Ottawa
| 4 ans |
| Stephen Kwai | M | - |
University of Ottawa
| 4 ans |
| Fanny McKellips | F | - |
University of Ottawa
| 4 ans |
| Mark Mannebach | M | - | - | |
| Jocelyn Trokenheim | F | - | 1 ans | |
| Wen Bo Wang | M | - | - | |
| Gordon F. Beck | M | - |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | - |
| Thy Dinh | M | - |
University of Ottawa
| 8 ans |
| Nabila Ali | F | 41 |
University of Ottawa
| 3 ans |
| Douglas E. Feltner | M | 64 | 2 ans | |
| Emil M. deGoma | M | - | - | |
| Ekambar R. Kandimalla | M | - | 4 ans | |
| Gregory J. Lynch | M | 55 | 4 ans | |
| Joseph Kipfer | M | - |
University of Ottawa
| 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 46 | 77,97% |
| Canada | 13 | 22,03% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- David Snyder
- Réseau Personnel
